Skyepharma Production

Skyepharma is a CDMO that specialises in the manufacture of traditional and advanced solid dosage forms, including single-layer tablets, multi-layer tablets, hard gel capsules, tab-in-tab, tab-in-cap, and sachet formulations. It provides solutions bringing value to its clients at any stage of a product development lifecycle, from early-stage development up to commercial manufacturing and packaging activities.

The company’s value proposition includes services tailored to clients’ requirements, supporting them up to market for their solid dosage form projects.

Skyepharma is a wholly owned subsidiary of Vectura, which acquired it in 2016 for £440 million.